Загрузка...

Omalizumab usage in chronic urticaria and atopic dermatitis: data from South-East province of Turkey

INTRODUCTION: Omalizumab is a current treatment option for IgE-associated dermatoses, such as urticaria and atopic dermatitis. AIM: To evaluate the clinical and laboratory findings of patients with chronic urticaria and atopic dermatitis who received omalizumab. MATERIAL AND METHODS: This study was...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Postepy Dermatol Alergol
Главные авторы: Nazik, Hülya, Mülayim, Mehmet Kamil, Öztürk, Perihan
Формат: Artigo
Язык:Inglês
Опубликовано: Termedia Publishing House 2019
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6986296/
https://ncbi.nlm.nih.gov/pubmed/31998003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ada.2019.91424
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!